Skip to Main Content

Paper Details

Reply to: "COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated".
Journal of the American Academy of Dermatology
0
2022
IMID, patients, rituximab
Author NameAffiliation
Hossein EstiriMassachusetts General Hospital
  • 1 - 1

Datasets

Release 1.2